PMID- 32877886 OWN - NLM STAT- MEDLINE DCOM- 20210609 LR - 20210609 IS - 1532-3064 (Electronic) IS - 0954-6111 (Linking) VI - 172 DP - 2020 Oct TI - Effects of peripheral and different inspiratory muscle training methods in coronary artery disease patients with metabolic syndrome: A randomized-controlled trial. PG - 106119 LID - S0954-6111(20)30259-6 [pii] LID - 10.1016/j.rmed.2020.106119 [doi] AB - Background OBJECTIVE: To investigate the effects of peripheral muscle training (PMT) and different inspiratory muscle training (IMT) methods on respiratory functions, exercise capacity, and biochemistry parameters in coronary artery disease patients with metabolic syndrome. METHODS: This prospective, single-blind, randomized-controlled study included 60 patients of stable coronary artery disease with metabolic syndrome (New York Heart Association [NYHA] Class I-II, left ventricular ejection fraction >40%). Patients were randomly divided into three groups: neuromuscular electrical stimulation (NMES) plus PMT group (NMES + PMT group, n = 20), IMT plus PMT group (IMT + PMT group, n = 20) and PMT group (PMT group, n = 20). Treatment continued for six weeks for all groups. The NMES was applied to rectus abdominis, IMT was applied with 30% of maximal inspiratory pressures, and PMT was applied at home. Spirometry, maximal inspiratory and expiratory pressure, dyspnea scores, exercise stress test, and biochemistry parameters were measured before and after training. RESULTS: There were significant improvements in spirometric tests, respiratory muscle strength, dyspnea scores, exercise capacity, fasting blood glucose, and antistreptolysin O after treatment in all groups (p < 0.05). Significant improvements in C-reactive protein and erythrocyte sedimentation rate were observed in NMES + PMT and IMT + PMT groups (p < 0.05). Among the groups, there was a significant difference in maximal inspiratory pressure (p = 0.02) and erythrocyte sedimentation rate (p = 0.037) in favor of NMES + PMT group (p < 0.05). CONCLUSION: Our study results showed significant improvements in respiratory functions, exercise capacity, and biochemistry markers in all groups. Different IMT methods can be used in cardiopulmonary rehabilitation to improve exercise intolerance in coronary artery disease patients with metabolic syndrome. CLINICAL TRIAL REGISTRATION NUMBER: NCT03523026. CI - Copyright (c) 2020 Elsevier Ltd. All rights reserved. FAU - Muammer, Kiymet AU - Muammer K AD - Department of Cardiology, Cardiology Institute, Istanbul University-Cerrahpasa, Istanbul, Turkey. FAU - Mutluay, Fatma AU - Mutluay F AD - Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Medipol University, Istanbul, Turkey. Electronic address: fmutluay@medipol.edu.tr. FAU - Demir, Rengin AU - Demir R AD - Department of Cardiology, Cardiology Institute, Istanbul University-Cerrahpasa, Istanbul, Turkey. FAU - Ozkan, Alev Arat AU - Ozkan AA AD - Department of Cardiology, Cardiology Institute, Istanbul University-Cerrahpasa, Istanbul, Turkey. LA - eng SI - ClinicalTrials.gov/NCT03523026 PT - Journal Article PT - Randomized Controlled Trial DEP - 20200822 PL - England TA - Respir Med JT - Respiratory medicine JID - 8908438 RN - 0 (Blood Glucose) RN - 9006-92-2 (Antistreptolysin) RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Adult MH - Aged MH - Antistreptolysin/metabolism MH - Blood Glucose/metabolism MH - Blood Sedimentation MH - Breathing Exercises/*methods MH - C-Reactive Protein/metabolism MH - Coronary Artery Disease/etiology/metabolism/*physiopathology/*rehabilitation MH - Electric Stimulation Therapy MH - *Exercise Tolerance MH - Fasting MH - Female MH - Humans MH - Male MH - Metabolic Syndrome/complications/metabolism/*physiopathology/*rehabilitation MH - Middle Aged MH - Muscle Strength MH - Prospective Studies MH - Respiratory Muscles/*physiology MH - Spirometry MH - Treatment Outcome OTO - NOTNLM OT - Coronary artery disease OT - Inspiratory muscle training OT - Metabolic syndrome OT - Neuromuscular electrical stimulation OT - Peripheral muscle training EDAT- 2020/09/03 06:00 MHDA- 2021/06/10 06:00 CRDT- 2020/09/03 06:00 PHST- 2020/06/02 00:00 [received] PHST- 2020/08/08 00:00 [revised] PHST- 2020/08/10 00:00 [accepted] PHST- 2020/09/03 06:00 [pubmed] PHST- 2021/06/10 06:00 [medline] PHST- 2020/09/03 06:00 [entrez] AID - S0954-6111(20)30259-6 [pii] AID - 10.1016/j.rmed.2020.106119 [doi] PST - ppublish SO - Respir Med. 2020 Oct;172:106119. doi: 10.1016/j.rmed.2020.106119. Epub 2020 Aug 22.